Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
03/16/2000 | WO2000013573A1 Monitoring methods using particle delivery methods |
03/16/2000 | WO2000013509A1 Method of determining and reducing the risk of bph-related urologic events |
03/16/2000 | WO2000002897A3 Delta cleavage products and methods based thereon |
03/16/2000 | WO2000000809A3 Test for oxidative stress using cell suspensions |
03/16/2000 | WO2000000082A8 Disposable article having proactive sensor |
03/16/2000 | WO1999067645A9 Non-invasive transdermal detection of analytes |
03/16/2000 | WO1999065937A9 Truncated apaf-1 and methods of use thereof |
03/16/2000 | WO1999064863A9 Colloidal colorimetric flow through and lateral flow assays utilizing soluble submicron particles |
03/16/2000 | WO1999064592A9 Green fluorescent proteins for measuring the ph of a biological sample |
03/16/2000 | WO1999064047A9 Novel antiviral compounds |
03/16/2000 | WO1999063932A9 Multibinding agents that modulate the 5-ht transporter |
03/16/2000 | WO1999063929A9 Multibinding inhibitors of microsomal triglyceride transferase protein |
03/16/2000 | WO1999063904A3 Method, device and agents for removing caries in a cavity |
03/16/2000 | WO1999062939A3 Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
03/16/2000 | WO1999061471A3 Human transmembrane proteins |
03/16/2000 | WO1999060094A3 Method for measuring the interaction of chemicals with cells |
03/16/2000 | WO1999058965A3 Evaluating properties of oil using dielectric spectroscopy |
03/16/2000 | WO1999058559B1 Factors affecting tumor necrosis factor receptor releasing enzyme activity |
03/16/2000 | WO1999057151A3 FAP α-SPECIFIC ANTIBODY WITH IMPROVED PRODUCIBILITY |
03/16/2000 | WO1999046385A3 Compositions and methods for the treatment and prevention of metastatic disorders |
03/16/2000 | WO1998049327A8 Recombinant fusion proteines based on bacterial adhesines for diagnostic assays |
03/16/2000 | DE19853398C1 Identification of 5-methylcytosine positions in genomic DNA by chemical modification, amplification and heteroduplex formation |
03/16/2000 | DE19842012A1 Verfahren zur Feststellung von Erdreichkontamination unter einer Dichtungsbahn Method for the detection of soil contamination under a geomembrane |
03/16/2000 | DE19841814A1 Breakthrough control on a gaseous adsorber comprises sensor array of semiconductor probes with sensitivity specific to a controlled species |
03/16/2000 | DE19841707A1 Reference electrode for galvanic cells with solid electrolytes made by applying a metal oxide and/or double oxide in liquid hydrosol or organosol form to the electrolyte to form a solid film |
03/16/2000 | DE19840570A1 Gas measurement process comprises comparing three wavelength emissions to minimize measuring errors and maximize signal resolution |
03/16/2000 | DE19839398A1 Mini-Basket zur Untersuchung der Wirkstoffreisetzung aus einer Arzneiform Mini-Basket for the investigation of drug release from a pharmaceutical form |
03/16/2000 | DE19836617A1 Verfahren zur Erkennung und Diagnostik akuter koronarer Syndrome A method of recognizing and diagnosing acute coronary syndroms |
03/16/2000 | DE19819575C1 Wasserstoffsensor Hydrogen sensor |
03/16/2000 | DE19819537A1 Analyse- und Diagnostikinstrument Analysis and diagnostic tool |
03/16/2000 | CA2347054A1 Linker-assisted immunoassay for glyphosate |
03/16/2000 | CA2344882A1 Laser-induced ionisation spectroscopy, particularly for coal |
03/16/2000 | CA2343136A1 Diagnostic method for detecting disturbances of the pancreas |
03/16/2000 | CA2342921A1 Drug screening and diagnosis based on paracrine tubular renin-angiotensin system |
03/16/2000 | CA2342897A1 Method of detection and disease state management for renal diseases |
03/16/2000 | CA2342832A1 Immunodiagnostics using particle delivery methods |
03/16/2000 | CA2342801A1 Monitoring methods using particle delivery methods |
03/16/2000 | CA2342785A1 Capillary printing systems |
03/16/2000 | CA2342734A1 Azo dye aqueous solution, preparation method and use |
03/16/2000 | CA2342627A1 Method for the rapid screening of analytes |
03/16/2000 | CA2342311A1 Novel protein kinase molecules and uses therefor |
03/16/2000 | CA2342280A1 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor |
03/16/2000 | CA2342027A1 Novel bag proteins and nucleic acid molecules encoding them |
03/16/2000 | CA2341782A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
03/16/2000 | CA2341778A1 Method for amplifying all dna fragments in a sample |
03/16/2000 | CA2341777A1 Neutral amino acid transporter and gene thereof |
03/16/2000 | CA2341753A1 Bifunctional antibodies and their use in targeting anti-tumour agents |
03/16/2000 | CA2341498A1 Temperature dependent protein purification |
03/16/2000 | CA2341314A1 Method for studying protein interactions in vivo |
03/16/2000 | CA2341307A1 Antibody for detecting possibility of onset of bovine leukemia |
03/16/2000 | CA2341302A1 Lim domain protein homolog |
03/16/2000 | CA2341153A1 Monitor protein for measuring protein phosphorylation |
03/16/2000 | CA2340686A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof |
03/16/2000 | CA2340598A1 Modifications of the vegf receptor-2 protein and methods of use |
03/16/2000 | CA2340433A1 Tau as a marker for early cns damage |
03/16/2000 | CA2340361A1 Assays using crosslinkable immobilized nucleic acids |
03/16/2000 | CA2340323A1 Mc4-r as target for the identification of compounds used to treat drug addiction |
03/16/2000 | CA2339951A1 Semiconductor gas sensing |
03/16/2000 | CA2338384A1 Peptide fragments of cholera toxin b or enterotoxin b as vaccine adjuvants |
03/16/2000 | CA2309212A1 Essential bacterial genes and their use |
03/16/2000 | CA2307617A1 Sampling and analysis of reactions by trapping reaction components on a sorbent |
03/15/2000 | EP0985932A1 Method for examining chronic rejection reactions following organ transplantation and method for determining urine components |
03/15/2000 | EP0985931A2 Recombinant antigen immunoassay for the diagnosis of syphilis |
03/15/2000 | EP0985930A2 Visual blood glucose test strip |
03/15/2000 | EP0985929A1 Aqueous solution with azo-dye, its manufacturing method and utilization |
03/15/2000 | EP0985927A2 Scanner type fluorescence detection apparatus |
03/15/2000 | EP0985922A1 Nanosecond gate spectroscopic diagnostic device |
03/15/2000 | EP0985453A1 Centrifuge chamber for a cell separator |
03/15/2000 | EP0985191A1 A method and a system for nucleic acid sequence analysis |
03/15/2000 | EP0985150A1 Method for detecting cancer associated with altered concentrations of lysophospholipids |
03/15/2000 | EP0985149A1 Methods for evaluating tissue morphogenesis and activity |
03/15/2000 | EP0985147A1 Luminol tagged polymers for treatment of industrial systems |
03/15/2000 | EP0985142A2 System and apparaus for sequential processing of analytes |
03/15/2000 | EP0985052A1 METHODS AND COMPOSITIONS TO IDENTIFY SWINE GENETICALLY RESISTANT TO F18 $i(E. COLI) ASSOCIATED DISEASES |
03/15/2000 | EP0985046A1 A soluble vaccinia virus protein that binds chemokines |
03/15/2000 | EP0985039A2 Artificial antibody polypeptides |
03/15/2000 | EP0985038A1 Sodium channel receptor |
03/15/2000 | EP0985033A2 Polyvalent and polyclonal libraries |
03/15/2000 | EP0984985A2 Peptide analogues, and their uses in particular in pharmaceutical compositions and for diagnosis |
03/15/2000 | EP0984978A1 Band array display of polynucleotide separations |
03/15/2000 | EP0984830A1 Process control method for vented polymerizers |
03/15/2000 | EP0890093A4 System for determining analyte concentration |
03/15/2000 | EP0874983B1 Method and apparatus for determination of hemoglobin content of individual red blood cells |
03/15/2000 | EP0842434B1 Method for the quantitative measurement of human acute phase serum amyloid a protein; recombinant protein; specific antibody |
03/15/2000 | EP0775313B1 Method of capturing species from liquids and apparatus therefor |
03/15/2000 | EP0772771B1 Determining biodegradability of aspartic acid derivatives, degradable chelants, uses and compositions thereof |
03/15/2000 | EP0769956B1 USE OF A GnRH ANTAGONIST FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF GONADAL-STEROID CONDITIONS |
03/15/2000 | EP0721579B1 Non-spectrophotometric measurement of analyte concentrations and optical properties of objects |
03/15/2000 | EP0715716B1 Bowed framed membrane, processes for the preparation thereof, and uses therefor |
03/15/2000 | EP0677170B1 Test strip for immunoassays |
03/15/2000 | EP0658205B1 Lipoprotein associated phospholipase a2, inhibitors thereof and use of the same in diagnosis and therapy |
03/15/2000 | EP0651788B1 Process for co-cultivating a type of cells with liver cells |
03/15/2000 | EP0648279B1 Acceptor for fucosyltransferase |
03/15/2000 | EP0641358B1 BINDING PEPTIDES WHICH INTERACT WITH LIGAND GROWTH FACTORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR AND erbB-2-RECEPTOR |
03/15/2000 | EP0609450B1 Method for high-sensitivity detection of amino acid derivative |
03/15/2000 | EP0551325B1 Method of testing for salmonella |
03/15/2000 | CN2369247Y Tester for flame hight of lighter |
03/15/2000 | CN1247601A Perforating analytical test device |
03/15/2000 | CN1247314A Blood sugar detecting strip available for perusal |
03/15/2000 | CN1247313A Solid developer and its preparing process and usage |